Extended-release pre-exposure prophylaxis and drug-resistant HIV
From MaRDI portal
Publication:6651982
Recommendations
- Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance
- Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Global dynamics and cost-effectiveness analysis of HIV pre-exposure prophylaxis and structured treatment interruptions based on a multi-scale model
- A mathematical model for treatment-resistant mutations of HIV
Cites work
- A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code
- A framework for model analysis across multiple experiment regimes: investigating effects of zinc on \textit{Xylella fastidiosa} as a case study
- A mathematical model for treatment-resistant mutations of HIV
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment
- Modeling the three stages in HIV infection
- Quantifying antiviral effects against simian/human immunodeficiency virus induced by host immune response
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
This page was built for publication: Extended-release pre-exposure prophylaxis and drug-resistant HIV
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6651982)
